47 results
Page 2 of 3
424B5
fy2wo8io70sdnvm
4 Feb 15
Prospectus supplement for primary offering
12:00am
424B5
nmyx11368 go9595
2 Feb 15
Prospectus supplement for primary offering
12:00am
8-K/A
EX-10.5
o31s0
28 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
dyzj6r
17 Jul 12
ZIOPHARM Oncology Announces New Executive Team
12:00am
8-K
EX-99.1
2e8l9llv0x
4 Jun 12
ZIOPHARM Oncology Completes Enrollment in PICASSO 3 Trial Evaluating Palifosfamide in Front-Line Metastatic Soft Tissue Sarcoma
12:00am
8-K
EX-1.1
fczhf
7 Feb 11
Ziopharm Prices Public Offering of Common Stock
12:00am
8-K
EX-99.1
y8ob5t5k mkkdp9775v
20 Jul 10
ZIOPHARM Announces Initiation of Palifosfamide Pivotal Study
12:00am
8-K
EX-99.1
bk9dqve
6 Apr 10
ZIOPHARM Elects George B. Abercrombie, former CEO of
12:00am
8-K
EX-99.1
opbj991 adsng1
14 Oct 09
ZIOPHARM Announces Positive Palifosfamide Sarcoma
12:00am
10QSB
EX-10.2
ol6th yzm
13 Nov 06
Quarterly report (small business)
12:00am
8-K
EX-99.1
stoxjl3krrupoyyb 1hy
3 May 06
Unregistered Sales of Equity Securities
12:00am
424B3
xzuzk00u sx2205u4d
14 Apr 06
Prospectus supplement
12:00am